Cargando…
Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5’-Flanking Region
Oestrogens influence the pathology and development of hormone-sensitive breast cancers. Tissue factor pathway inhibitor (TFPI) has been shown to be associated with breast cancer pathogenesis. Recently, we found TFPI mRNA levels to be significantly reduced by oestrogens in a breast cancer cell line (...
Autores principales: | Ali, Huda Omar, Stavik, Benedicte, Myklebust, Christiane Filion, Andersen, Elisabeth, Dahm, Anders E. A., Iversen, Nina, Sandset, Per Morten, Skretting, Grethe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801176/ https://www.ncbi.nlm.nih.gov/pubmed/26999742 http://dx.doi.org/10.1371/journal.pone.0152114 |
Ejemplares similares
-
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
por: Stavik, Benedicte, et al.
Publicado: (2013) -
Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
por: Stavik, Benedicte, et al.
Publicado: (2011) -
Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
por: Andresen, Marianne S., et al.
Publicado: (2020) -
TFPI Alpha and Beta Regulate mRNAs and microRNAs Involved in Cancer Biology and in the Immune System in Breast Cancer Cells
por: Stavik, Benedicte, et al.
Publicado: (2012) -
Syndecan-3 and TFPI Colocalize on the Surface of Endothelial-, Smooth Muscle-, and Cancer Cells
por: Tinholt, Mari, et al.
Publicado: (2015)